Gout and Women’s Heart Disease: How Uric Acid Drags Down Your Heart

A 49-Year-Old Woman’s Heart Was Failing. Nobody Checked Her Uric Acid.

Her ejection fraction was 17%. For context, a healthy heart pumps out 50 to 70% of its blood with each beat. Hers was barely squeezing out a sixth. She had biventricular dilatation, severe tricuspid regurgitation, and a BNP of 12,029 pg/mL (normal is under 100). By every measure, her heart was shutting down.

She was 49. She also had gout.

This real case, published in Rheumatology Advances in Practice in November 2025 from Great Western NHS Foundation Trust in the UK, is not an outlier. It is a window into something researchers have been warning about for years: high uric acid does not just wreck your joints. It damages your heart. And women with gout may be hit the hardest.

Women With Gout Face Nearly Double the Heart Risk

In February 2024, a landmark study in The Lancet Rheumatology analyzed health records from over 860,000 people. The finding that made headlines: women with gout had an 88% higher relative risk of cardiovascular disease compared to women without gout. Men with gout? Their risk was 49% higher.

That gap matters. Women are already underdiagnosed when it comes to gout, as we have explained before. Many doctors still think of gout as a “rich man’s disease” that hits older men after too much steak and beer. When a woman shows up with joint pain, she is far more likely to be sent home with an arthritis diagnosis and no uric acid test.

But the heart connection is where the stakes get really high. A separate meta-analysis of 22 studies found that people with gout have 2.71 times the risk of heart failure compared to those without gout. And among people with gout, women actually carried a higher risk of heart attack or heart failure than men.

How Uric Acid Quietly Damages Your Heart

Here is where most people get it wrong. They think uric acid is just a waste product that crystallizes in joints and causes pain. That is like saying a fire only burns what it touches directly.

Uric acid is produced by an enzyme called xanthine oxidase. When this enzyme is overactive, it does not just make uric acid. It also pumps out reactive oxygen species, or ROS. Think of ROS as cellular exhaust fumes. They damage the lining of your blood vessels, reduce nitric oxide availability (the molecule that tells your vessels to relax), and trigger chronic inflammation.

The result? Your blood vessels get stiff. Your heart muscle struggles to get enough oxygen. The left ventricle, the main pumping chamber, starts to weaken. Over time, this leads to left ventricular dysfunction and, eventually, heart failure.

A review published in Frontiers in Endocrinology put it plainly: xanthine oxidase-driven uric acid production contributes to oxidative stress, endothelial dysfunction, vascular inflammation, and left ventricular dysfunction. In other words, the same enzyme that causes your gout flares is also slowly breaking down your heart.

The numbers back this up. The Cardiovascular Health Study found that for every 1 mg/dL increase in serum uric acid, the risk of new-onset heart failure goes up 12%. NHANES data shows that about 50% of heart failure patients have hyperuricemia. This is not a fringe association. It is mainstream cardiology.

Why Women Get the Short End of the Stick

Estrogen helps the kidneys excrete uric acid. Before menopause, women naturally have lower uric acid levels than men. But after menopause, estrogen drops, and uric acid climbs. We covered this in detail in our article on what happens when estrogen disappears.

Here is the problem: many women hit menopause and start dealing with other health issues at the same time. Blood pressure goes up. Weight creeps on. Doctors prescribe diuretics for blood pressure, and as we discussed in our piece on diuretics and women’s gout, loop diuretics like furosemide raise uric acid levels. So you have a woman whose estrogen protection is gone, whose blood pressure medication is pushing uric acid higher, and whose kidneys may already be slowing down.

Then add the fact that women’s gout is more likely to be misdiagnosed. A woman with polyarticular gout (multiple joints affected) often gets labeled with rheumatoid arthritis first. While she waits for the right diagnosis, her uric acid stays high, and her heart keeps taking hits.

The Case That Proved It: EF 17% Back to 54%

Let us go back to that 49-year-old woman in the UK. Her story is remarkable, and it is worth understanding in detail.

She came in with severe menorrhagia (heavy menstrual bleeding) that had gone on for three years. This caused iron deficiency anemia so severe her hemoglobin was 59 g/L (normal for women is 120 to 150). The anemia strained her heart, leading to heart failure with an ejection fraction of 17%.

She received iron infusions, blood transfusions, and medications including furosemide (a loop diuretic), bisoprolol, dapagliflozin, and ramipril. Three months later, she developed symmetric joint swelling in her hands and acute kidney injury. Her serum uric acid was 672 micromol/L (about 11.3 mg/dL, well above the 6 mg/dL threshold for women). She had visible tophi on her fingers and toes.

Her doctors stopped the furosemide (which was raising her uric acid) and started allopurinol and colchicine. They titrated the allopurinol dose based on her kidney function and uric acid levels.

One month later, an echocardiogram showed her ejection fraction had recovered to 54%. Her tricuspid regurgitation was down to “trivial.” Her uric acid had dropped to 358 micromol/L (about 6.0 mg/dL). Her tophi were shrinking. Her joint symptoms were improving.

Was it just the iron and blood transfusions that fixed her heart? Partially, yes. But the urate-lowering therapy played a role too. Here is why: allopurinol does not just lower uric acid. It inhibits xanthine oxidase, which means it also reduces the production of those reactive oxygen species damaging her heart muscle. Research has shown that allopurinol can improve myocardial efficiency, reduce oxygen consumption in the heart, and even promote reverse remodeling of the left ventricle.

The case report authors noted that urate-lowering therapy “not only improved articular symptoms but also coincided with reversal of cardiac dysfunction, supporting uric acid’s pathogenic role.”

What Should You Do If You Have Gout and Care About Your Heart?

If you have gout, here is what the evidence says you should be doing:

1. Get your uric acid to target. The goal is below 6 mg/dL (360 micromol/L). If you have tophi, the target is even lower: below 5 mg/dL (300 micromol/L). This is not optional. High uric acid is not just about joint pain. It is actively damaging your cardiovascular system.

2. Ask about allopurinol. Allopurinol is the first-line urate-lowering medication. It is cheap, well-studied, and has the added benefit of reducing oxidative stress in the heart. If you have heart issues, this dual action matters. You can read more about how allopurinol compares to febuxostat in our article on febuxostat and cardiovascular safety.

3. Review your medications. If you are on diuretics for blood pressure or heart failure, ask your doctor whether they are raising your uric acid. Loop diuretics and thiazides both do this. The 2024 Chinese guidelines for hyperuricemia and gout management explicitly recommend minimizing thiazide diuretics and using loop diuretics only with close monitoring of serum uric acid levels.

4. Ask about SGLT2 inhibitors. Drugs like dapagliflozin and empagliflozin lower blood sugar (for diabetes), improve heart failure outcomes, and lower uric acid by about 1 mg/dL. The 2024 guidelines prioritize SGLT2 inhibitors for heart failure patients with hyperuricemia. The woman in the UK case was already on dapagliflozin.

5. Get your heart checked. If you have gout and have never had an echocardiogram or a cardiac risk assessment, ask for one. The Lancet study found that gout increased the risk across all 12 cardiovascular diseases they studied, including heart failure, ischemic heart disease, arrhythmias, and valve disease. We cover some of these connections in our article on gout complications.

What the Guidelines Actually Say

The 2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout includes specific recommendations for heart failure patients:

• Alongside appropriate urate-lowering therapy, ARNI (angiotensin receptor-neprilysin inhibitors) and SGLT2 inhibitors are prioritized for heart failure management.
• Losartan potassium is recommended for hypertension treatment in these patients (it has mild uricosuric effects).
• Thiazide diuretics should be minimized, and loop diuretics used only with close monitoring of uric acid levels.

The European Society of Cardiology includes uric acid in a prognostic model for heart failure, though they do not yet formally address hyperuricemia treatment in HF guidelines. The gap between evidence and formal guidelines is real, but the research is building fast.

A UK heart failure registry study by Struthers and colleagues found that high-dose allopurinol (300 mg/day or more) over four years reduced hospitalization and mortality rates in hyperuricemic heart failure patients down to the levels of patients with normal uric acid. Low-dose allopurinol (under 300 mg/day), however, actually increased death risk by 104%. The dose matters. You need enough to actually hit your uric acid target.

The Bottom Line

Gout is not just a joint disease. It is a metabolic condition with real cardiovascular consequences, and women face a disproportionately higher risk. The 49-year-old woman in the UK went from an ejection fraction of 17% to 54% in part because her doctors recognized the uric acid connection and acted on it.

If you have gout, your uric acid number is not just about whether your toe hurts. It is about whether your heart can keep pumping. Get tested, get treated, and get to target. Your joints and your heart will both thank you.

Frequently Asked Questions

Can lowering uric acid actually improve heart function?

Yes. The UK case study showed ejection fraction improving from 17% to 54% after urate-lowering therapy. Research on allopurinol shows it improves myocardial efficiency by reducing oxidative stress and oxygen consumption in the heart muscle. The benefit appears strongest in people who achieve their uric acid target with adequate dosing.

Why do women with gout have higher heart risk than men?

Several factors play a role. After menopause, women lose estrogen’s uric acid-lowering protection. Women are also more likely to be prescribed diuretics (which raise uric acid) for blood pressure or heart conditions. On top of that, women’s gout is often diagnosed later, meaning high uric acid damages the cardiovascular system for longer before treatment begins.

Should I stop taking my diuretic if I have gout?

No. Do not stop any medication on your own. But do talk to your doctor about alternatives. The 2024 guidelines recommend minimizing thiazide diuretics and using losartan (which has uric acid-lowering effects) as a preferred blood pressure medication. If you need a diuretic for heart failure, your doctor should monitor your uric acid closely and adjust your urate-lowering therapy accordingly.

What uric acid level is safe for my heart?

The standard gout target is below 6 mg/dL (360 micromol/L). For people with tophi or frequent flares, the target is below 5 mg/dL (300 micromol/L). For heart health specifically, research suggests that the lower your uric acid, the lower your cardiovascular risk. The Cardiovascular Health Study found a linear relationship: each 1 mg/dL increase in uric acid raised heart failure risk by 12%.

Is allopurinol safe if I have heart disease?

Allopurinol is generally safe for people with heart disease and may actually benefit cardiac function through its xanthine oxidase inhibition. However, dosing needs to be adjusted for kidney function, and you should start low and titrate up. The UK registry study showed that high-dose allopurinol (300+ mg/day) improved heart failure outcomes, while low-dose allopurinol was associated with worse outcomes. Always work with your doctor to find the right dose.

Does having gout mean I will definitely get heart disease?

No. Having gout increases your risk, but it is not a guarantee. The Lancet study showed a 58% higher overall cardiovascular risk for people with gout, with women at 88% higher risk. But risk is not destiny. Getting your uric acid to target, managing blood pressure and cholesterol, staying active, and eating well can significantly reduce your cardiovascular risk. A UK Biobank study found that favorable lifestyle patterns reduced cardiovascular risk in people with gout across all uric acid levels.

Reviewed by the GoutSavvy Editorial Team